Baroque Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 135 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with NAFDAC (NG), DIGEMAPS (DO) and DAV (Vietnam). Its GMP standing is certified by CDSCO (India), EMA and NAFDAC (NG). Customs aggregates show $10.7M of exports covering 527 molecules to 25 destinations in 2025.
| Site | FDA FEI |
|---|---|
| tal khambhat khambhat 388 620 anand, India | Not on file |
| Anand, India | Not on file |
| 388 620tal khambhatsokhada 388 620anand, India | Not on file |
| Anand, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NAFDAC (NG) | 55 | 1 |
| DIGEMAPS (DO) | 50 | None |
| DAV (Vietnam) | 16 | None |
| ARCSA (EC) | 5 | None |
| SAHPRA (ZA) | 2 | None |
| UZPHARM (UZ) | 2 | None |
| CDSCO (India) | None | 3 |
| EMA | None | 3 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.4M | 10 |
| 2025 | Not reported | $10.7M | 25 |
| 2024 | Not reported | $10.7M | 19 |
| 2023 | Not reported | $9.4M | 18 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Baroque Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free